|


|
How Does Obesity Impact Other Aspects of a Patient's
Health
Endocrine researchers are devoting much time and energy to
observing how obesity impacts other aspects of a patient’s health. It is
vital for endocrinologists to have the full picture of how obesity has a hand in either causing or contributing to serious obesity-related
health conditions (diabetes, metabolic syndrome, hypertension, PCOS). Obesity is truly multifactorial and to be fully
effective in treating and managing obesity, endocrinologists need
to understand its implications. Key research developments examining the
pathophysiology of obesity include:
Key research developments examining the pathophysiology of
obesity include:
Identifying the Fat Cell as an
Endocrine Cell/Organ There are two prime examples of the impact
fat cells have on obesity and a patient’s health:
- Obesity inherently reflects an increased amount of
fat cells and increased body mass (body mass index or BMI). Increased body mass causes conditions
such as osteoarthritis and sleep apnea.
- The discovery of leptin allowed for the
acknowledgement by researchers that fat is an endocrine cell105. (Please see sidebar for more information.) In
addition to leptin, there are increased amounts of other peptides in the
body that are affected by an increase in fat cells. At times, these
proteins may alter – either slow or accelerate – the normal metabolic
functioning of the body. Such metabolic changes tend to lead to
complications, including the development of hyperinsulinemia,
atherosclerosis or hypertension,
and physical stress put on bones and joints.
Clarifying the Impact of Body Fat
Distribution on Obesity People with an uneven distribution of
fat in their upper body (upper body obesity), and especially inside the abdomen, are prone to
developing insulin resistance, Type 2
diabetes, abnormal blood lipid patterns associated with premature
cardiovascular disease, as well as hypertension.
Endocrine research has shown that elevated levels of free fatty acids
(acids released primarily by fat cells and used for energy within the
body) into the bloodstream can cause insulin resistance, abnormal
production of triglycerides by the liver and blood vessel responses that
can lead to hypertension. People with upper body obesity have elevated
levels of free fatty acids and are therefore at higher risk for a number
of other health problems seen in obesity. In addition, intra-abdominal fat
has been shown to send excess free fatty acids to the liver, thereby
causing the liver to produce too much glucose and triglycerides.
Understanding Obesity’s Impact on Other
Health Conditions Through important scientific and clinical
research, endocrinologists are helping to build a framework from which
clinicians are better able to address the root causes of obesity and to
effectively assist with the management of obesity-related conditions. To
date, some of the most compelling endocrine-related research has come from
examining the link between
obesity and diabetes.
|
What is the Diabetes Prevention Program
(DPP)? The Diabetes Prevention Program (DPP) was a major
clinical trial, conducted primarily by endocrinologists, that looked
at whether diet and exercise or the diabetes drug metformin
(Glucophage) could prevent or delay the onset of Type 2 diabetes in
people with impaired glucose tolerance (IGT).
Why is it considered groundbreaking
endocrine research? Groundbreaking research from the DPP
found that over the three years of the study, diet and exercise
sharply reduced the chances that a person with IGT would develop
diabetes. Metformin also reduced risk, although less dramatically.
The DPP resolved these questions so quickly that, on the advice of
an external monitoring board, the program was halted a year early.
The researchers published their findings in the New England Journal
of Medicine in February 2002.
The DPP's results demonstrated that millions of high-risk people
can use diet, exercise, weight loss, and behavior modification to avoid
developing Type 2 diabetes. The DPP also suggests that metformin is
effective in delaying the onset of diabetes. Future research and
analysis will continue to examine and determine the true
relationship between exercise and diet and the reduction of
diabetes. |
Through important medical research on obesity and obesity-related complications – much of it being
conducted by endocrinologists – we are beginning to understand that
obesity has many underlying medical causes, which may not be controlled by
diet and exercise. We must move beyond stigma and dedicate ourselves to
combating obesity on all fronts – behavioral, nutritional and metabolic –
a concept endocrine researchers are currently addressing.
Examining the Link Between Exercise and
Obesity Endocrine
researchers are actively exploring the link between exercise and
activity and their impact on weight gain/weight loss. The National Weight
Control Registry (NWCR), an ongoing, longitudinal prospective study led by
endocrinologists Dr. James Hill of the University of Colorado and Dr. Rena
Wing of Brown University and University of Pittsburgh, is examining
individuals 18 years and older, who have successfully maintained a 30
pound weight loss for a minimum of one year. Currently, the weight loss study registry is
comprised of nearly 3,000 individuals. The weight loss study is investigating and
disproving one of the most popular myths about weight loss – that everyone
who experiences weight loss will eventually gain it back. In recent years, the NWCR
has reported that maintaining weight loss is easier than the initial loss
of weight. In the trial, maintenance of weight loss is typically
associated with continued consumption of a healthy low-calorie diet.
Although there appears to be no evidence of increased metabolic efficiency
in those who successfully lost weight, NWCR has identified a correlation
between duration of weight loss maintenance and the effort required to
maintain such weight loss (as the duration increases, effort required
tends to decrease).
|